Updates

Final Finding issued recommending anti-dumping duties on imports of ‘Glufosinate and its salt’ originating in or exported from China PR (10.02.2025)

Product Description- The product under considerationisGlufosinate and its salts, both in technical and formulation form.

HS Codes – The product under consideration does not have a dedicated classification. The product is imported under 38089190, 38089390, and 38089990.

Uses – Glufosinate is used in modern agriculture for weed control and versatility across various crops. The primary application is in row crop farming, where it is applied before or during plantation to suppress the unwanted vegetation.

Country involved- China PR

Applicants – UPL Limited, Astral Life India Limited, United Phosphorus (India) LLP, UPL Sustainable Agri Solutions Limited and Swal Corporation Limited.

Period of investigation – 1st January 2023 to 31st December 2023.

Injury period – 1st April 2020- 31st March 2021, 1st April 2021 – 31st March 2022, 1st April 2022- 31st March 2023 and the period of investigation.

Margins and recommended Duties:

SN Producers(s) Dumping margin (%) Injury margin (%) Duty ($/MT)
1 Any producer 20-30% 20-30% 2,998

Key findings:

  1. The product under consideration is Glufosinate and its salts, in both technical and formulation forms. All forms of glufosinate are within the scope of the product under consideration.
  2. While the product under consideration is imported in technical form, it is consumed in formulation form. Conversion of technical to formulation form is merely an incremental process. Glufosinate technical and Glufosinate formulation are not distinct products, but simply different forms of the same product.
  3. The Authority has considered that companies without manufacturing facilities to produce Glufosinate technical and only engaged in mere formulation from the technical form cannot be considered part of the domestic industry within the meaning of Rule 2(b).
  4. The applicants are the sole producer of technical form of the product. The application satisfies the criteria of standing in terms of Rule 5(3). Production of the applicant constitutes a major proportion in the total Indian production.
  5. The Authority has considered that the imports made in the SEZ units are not considered as the same has not been consumed in the domestic market.
  6. Imports made by SEZ unit are not significant in proportion to the production undertaken by the applicants and thus do not alter the predominant manufacturing status of the applicants.
  7. The total imports have shot up from 590 MT in the base year to 1296 MT in the period of investigation. The imports in past were for export purpose. The imports for consumption in the domestic market started in 2022-23 and increased sharply in the period of investigation.
  8. Import price of the product declined steeply over the injury period. As the import price declined significantly, the volume of imports significantly increased and in a short duration.
  9. The import price of glufosinate technical is materially below the cost of sales of technical form produced by the domestic industry.
  10. Dumped imports have forced the domestic industry to shut down their production. Plant of the domestic industry were shut down for the period October to December during the period of investigation.
  11. The imposition of anti-dumping duty does not restrict imports; they will continue at a fair price. The purpose of anti-dumping measures is to ensure that imports enter the Indian market at a fair price and create a level playing field.
  12. The Authority noted that impact of recommended duties on the end users would be insignificant.
  13. Given the nature of the product, industry and the extent of the injury caused by dumped imports, the Authority considers the imposition of anti-dumping duty for a period of five 5 years.